IP Library Granted Patent US 10,093,973
Granted Patent B2
US 10,093,973 · App. 15/169,854 · Granted Oct 9, 2018

Polymerase compositions and methods

Inventors: Stephen P. Hendricks (Los Gatos, CA); Michael Phelan (Millbrae, CA); Marian Peris (San Mateo, CA); Cheng-Yao Chen (San Diego, CA); Daniel Mazur (San Diego, CA); Xinzhan Peng (Carlsbad, CA); Amy Castillo (Houston, TX)
Assignee: LIFE TECHNOLOGIES CORPORATION
C12Q1/6869C07H19/20C12N9/1241C12N9/1252C12N9/96C12Q1/6818G01N21/6428G01N33/582C12Y207/07C12Y207/07007G01N2021/6432
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,093,973
App. No.
15/169,854
Granted
Oct 9, 2018
Kind
B2
Abstract

Disclosed herein are modified polymerase compositions exhibiting altered polymerase activity, which can be useful in a variety of biological applications. Also disclosed herein are methods of making and using such compositions. In some embodiments, the compositions exhibit altered properties that can enhance their utility in a variety of biological applications. Such altered properties, can include, for example, altered nucleotide binding affinities, altered nucleotide incorporation kinetics, altered photostability and/or altered nanoparticle tolerance, as well as a range of other properties as disclosed herein.

Claims (17)

1. A method for performing a primer extension reaction, comprising: contacting a modified polymerase comprising the amino acid sequence of SEQ ID NO: 7 with a nucleic acid molecule and a nucleotide under conditions where the nucleotide is incorporated into the nucleic acid molecule by the polymerase.

2. The method of claim 1 , wherein the nucleotide is a labeled nucleotide, and the label of the nucleotide emits a signal during incorporation of the nucleotide.

3. The method of claim 2 , further comprising detecting the signal emitted by the nucleotide label.

4. The method of claim 3 , further comprising analyzing the detected signal to determine the identity of the incorporated nucleotide.

5. The method of claim 1 , wherein the modified polymerase exhibits a ti value for a labeled nucleotide that is equal to or greater than the t −1 value of a reference Phi-29 polymerase comprising the amino acid sequence of SEQ ID NO: 1 for the same nucleotide.

6. The method of claim 1 , wherein the modified polymerase exhibits a t pol value for a labeled nucleotide that is equal to or greater than the t pol value of a reference Phi-29 polymerase comprising the amino acid sequence of SEQ ID NO: 1 for the same nucleotide.

7. The method of claim 1 , wherein the modified polymerase exhibits a residence time for a labeled nucleotide that is equal to or greater than the residence time of a reference Phi-29 polymerase comprising the amino acid sequence of SEQ ID NO: 1 for the same nucleotide.

8. The method of claim 1 , wherein the modified polymerase has a photostability of at least about 80% under standard photostability assay conditions.

9. The method of claim 1 , wherein the modified polymerase has a nanoparticle tolerance of at least about 80% under standard tolerance assay conditions.

10. The method of claim 2 , wherein the labeled nucleotide comprises a nucleotide label linked to the base, sugar or phosphate group of the nucleotide.

11. The method of claim 2 , wherein the labeled nucleotide is a reversible terminator.

12. The method of claim 2 , wherein the modified polymerase is linked to a label.

13. The method of claim 1 , wherein the modified polymerase further comprises a peptide tag which includes the amino acid sequence MNHLVHHHHHHIEGRHMELGTLEGS (SEQ ID NO:51), wherein the peptide tag is linked to the N-terminal or C-terminal end of the modified DNA polymerase.

14. The method of claim 1 , wherein the modified polymerase further comprises a peptide tag which includes the amino acid sequence MHHHHHHKH (SEQ ID NO:52), wherein the peptide tag is linked to the N-terminal or C-terminal end of the modified DNA polymerase.

15. The method of claim 1 , wherein the modified polymerase further comprises a peptide tag which includes the amino acid sequence LLGAAAKGAAAKGSAA (SEQ ID NO:16), wherein the peptide tag is linked to the N-terminal or C-terminal end of the modified DNA polymerase.

16. The method of claim 1 , wherein the modified polymerase further comprises a peptide tag which includes the amino acid sequence LLGGGGSGGGGSAAAGSAA (SEQ ID NO:17), wherein the peptide tag is linked to the N-terminal or C-terminal end of the modified DNA polymerase.

17. The method of claim 1 , wherein the modified polymerase further comprises a peptide tag which includes the amino acid sequence GLNDIFEAQKIEWHE (SEQ ID NO:53), wherein the peptide tag is linked to the N-terminal or C-terminal end of the modified DNA polymerase.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2017
From: HENDRICKS, STEPHAN; PHELAN, MICHAEL; PERIS, MARIAN; CHEN, CHENG-YAO; MAZUR, DANIEL; PENG, XINZHAN; CASTILLO, AMY
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 042884/0065 →
Continuity (15)
Division 14710160 · May 12, 2015
Continuation 13540935 · Jul 3, 2012
Continuation 12748359 · Mar 26, 2010
Provisional Application 61164324 · Mar 27, 2009
Provisional Application 61184770 · Jun 5, 2009
Provisional Application 61242771 · Sep 15, 2009
Provisional Application 61245457 · Sep 24, 2009
Provisional Application 61263974 · Nov 24, 2009
Provisional Application 61289388 · Dec 22, 2009
Provisional Application 61293618 · Jan 8, 2010
Provisional Application 61293616 · Jan 8, 2010
Provisional Application 61299919 · Jan 29, 2010
Provisional Application 61299917 · Jan 29, 2010
Provisional Application 61307356 · Feb 23, 2010
Related Publication 20160265045A1 · Sep 15, 2016